ZA961591B - 4-aminotetrahydrobenzisoxazole or -isothiazole compounds - Google Patents

4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Info

Publication number
ZA961591B
ZA961591B ZA961591A ZA961591A ZA961591B ZA 961591 B ZA961591 B ZA 961591B ZA 961591 A ZA961591 A ZA 961591A ZA 961591 A ZA961591 A ZA 961591A ZA 961591 B ZA961591 B ZA 961591B
Authority
ZA
South Africa
Prior art keywords
aminotetrahydrobenzisoxazole
disorders
isothiazole compounds
disease
aminotetrahydrobenzisoxazoles
Prior art date
Application number
ZA961591A
Other languages
English (en)
Inventor
Erik Falch
Jens Kristian Perregaard
Arne Schousboe
Povl Krogsgaard-Larsen
Bente Frolund
Sibylle Moltzen Lenz
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of ZA961591B publication Critical patent/ZA961591B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nozzles (AREA)
ZA961591A 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds ZA961591B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK20795 1995-02-28

Publications (1)

Publication Number Publication Date
ZA961591B true ZA961591B (en) 1996-08-28

Family

ID=8090951

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA961591A ZA961591B (en) 1995-02-28 1996-02-28 4-aminotetrahydrobenzisoxazole or -isothiazole compounds

Country Status (31)

Country Link
US (2) US5998613A (xx)
EP (1) EP0812318B1 (xx)
JP (1) JPH11501016A (xx)
KR (1) KR100242675B1 (xx)
CN (1) CN1087290C (xx)
AT (1) ATE317391T1 (xx)
AU (1) AU697610B2 (xx)
BG (1) BG63258B1 (xx)
BR (1) BR9607443A (xx)
CA (1) CA2213127A1 (xx)
CZ (1) CZ290837B6 (xx)
DE (1) DE69635798T2 (xx)
DK (1) DK0812318T3 (xx)
EA (1) EA000380B1 (xx)
EE (1) EE03483B1 (xx)
ES (1) ES2253748T3 (xx)
FI (1) FI973519A0 (xx)
HK (1) HK1008527A1 (xx)
HU (1) HUP9800631A3 (xx)
IL (1) IL117295A (xx)
IS (1) IS2352B (xx)
NO (1) NO309474B1 (xx)
NZ (1) NZ301653A (xx)
PL (1) PL187404B1 (xx)
RO (1) RO119545B1 (xx)
SI (1) SI0812318T1 (xx)
SK (1) SK281879B6 (xx)
TR (1) TR199700873T1 (xx)
UA (1) UA43396C2 (xx)
WO (1) WO1996026929A1 (xx)
ZA (1) ZA961591B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69722426T3 (de) 1996-07-24 2015-05-07 Warner-Lambert Company LLC (n.Ges. des Staates Delaware) Isobutylgaba und dessen derivate zur schmerzbehandlung
GB9622370D0 (en) 1996-10-28 1997-01-08 Merck Sharp & Dohme Therapeutic agents
US20030166554A1 (en) * 2001-01-16 2003-09-04 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US20030185754A1 (en) * 2001-01-16 2003-10-02 Genset, S.A. Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
JP5478716B2 (ja) * 2009-05-05 2014-04-23 エフ.ホフマン−ラ ロシュ アーゲー 認識障害の処置において使用するためのgabaa受容体逆アゴニストとしてのイソオキサゾール−チアゾール誘導体
JP5732453B2 (ja) 2009-06-25 2015-06-10 アルカーメス ファーマ アイルランド リミテッド Nh酸性化合物のプロドラッグ
CN105758807B (zh) * 2016-02-22 2019-01-29 山东出入境检验检疫局检验检疫技术中心 一种鉴别废润滑油的方法
US11273158B2 (en) 2018-03-05 2022-03-15 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2602643C2 (de) * 1976-01-24 1984-12-20 Bayer Ag, 5090 Leverkusen 1,2-Benzisothiazolinone-3, Verfahren zu ihrer Herstellung sowie Arzneimittel
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
US4804663A (en) 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US5321037A (en) * 1986-12-26 1994-06-14 Sankyo Company, Limited Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants
ZA879631B (en) * 1986-12-26 1989-08-30 Sankyo Co Centrally-acting muscle relaxants
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
US5225412A (en) * 1991-04-29 1993-07-06 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides

Also Published As

Publication number Publication date
EP0812318A1 (en) 1997-12-17
PL321956A1 (en) 1998-01-05
NO973948L (no) 1997-08-27
IL117295A0 (en) 1996-06-18
KR19980702546A (ko) 1998-07-15
US6174909B1 (en) 2001-01-16
MX9706280A (es) 1998-06-30
IS2352B (is) 2008-04-15
TR199700873T1 (xx) 1998-01-21
BR9607443A (pt) 1998-05-26
SK115197A3 (en) 1998-02-04
AU697610B2 (en) 1998-10-15
CA2213127A1 (en) 1996-09-06
DE69635798T2 (de) 2006-08-17
EA199700199A1 (ru) 1998-02-26
WO1996026929A1 (en) 1996-09-06
EA000380B1 (ru) 1999-06-24
NO973948D0 (no) 1997-08-27
AU4713196A (en) 1996-09-18
CZ271197A3 (cs) 1998-03-18
PL187404B1 (pl) 2004-07-30
CN1087290C (zh) 2002-07-10
US5998613A (en) 1999-12-07
HK1008527A1 (en) 1999-07-30
DE69635798D1 (de) 2006-04-20
NZ301653A (en) 1998-12-23
DK0812318T3 (da) 2006-06-06
UA43396C2 (uk) 2001-12-17
ATE317391T1 (de) 2006-02-15
IL117295A (en) 1999-11-30
FI973519A (fi) 1997-08-27
BG63258B1 (bg) 2001-07-31
HUP9800631A2 (hu) 1998-08-28
NO309474B1 (no) 2001-02-05
SI0812318T1 (sl) 2006-06-30
RO119545B1 (ro) 2004-12-30
KR100242675B1 (ko) 2000-03-02
IS4542A (is) 1997-08-13
EE9700197A (et) 1998-02-16
BG101894A (en) 1998-05-29
ES2253748T3 (es) 2006-06-01
HUP9800631A3 (en) 1998-12-28
SK281879B6 (sk) 2001-08-06
EE03483B1 (et) 2001-08-15
CN1176638A (zh) 1998-03-18
CZ290837B6 (cs) 2002-10-16
JPH11501016A (ja) 1999-01-26
EP0812318B1 (en) 2006-02-08
FI973519A0 (fi) 1997-08-27

Similar Documents

Publication Publication Date Title
IL107843A0 (en) Aminomethylene substituted non-aromatic heterocycles
PH31123A (en) Benzimidazole compounds.
ZA924527B (en) Azanorbornane derivatives
FI941022A (fi) Spirosykliset piperidiinijohdannaiset
DE60224879D1 (de) Verwendung von dpiv-inhibitoren als therapeutika für krankhafte neurologische zustände
GR3029853T3 (en) Diazabicyclic neurokinin antagonists
SG157231A1 (en) Substituted p-diaminobenzene derivatives
IL117295A0 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
AP2003002873A0 (en) Pregabalin lactose conjugates
NO903726D0 (no) Rensing av 1,1-diklor-1-fluoretan.
MY121206A (en) Aminobenzamide compounds for the treatment of neurodegenerative disorders
DE69832302D1 (de) Antikonvulsive und zns-aktive bis-fluoralkylamide
PL343758A1 (en) Purification of carboxaldehyde
ES2087813A1 (es) Heterociclos no-aromaticos que contienen nitrogeno bencilamino substituidos.
ES2097688A1 (es) Hexahidroazepinonas y tetrahidrobenzazepinonas sustituidas.
WO2004042405A3 (en) Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3)